Description |
LDL receptor related protein 2 |
lipoprotein(a) |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Aortic valve stenosis ( 29511194)
- Aortic-valve calcification ( 23388002)
- Blood protein levels ( 28240269)
- Body mass index ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Cholesterol, total ( 24097068 28270201 25961943 20686565)
- Coronary artery disease ( 29212778 24262325 30104761 26343387 28714974)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- Coronary artery disease in diabetes ( 30003307)
- Coronary artery disease or ischemic stroke ( 24262325)
- Coronary artery disease or large artery stroke ( 24262325)
- Coronary heart disease ( 19198611 21378990)
- End stage renal disease x APOL1 genotype interaction ( 29885931)
- HDL cholesterol ( 25961943 20686565)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Heart failure ( 31919418)
- Ischemic stroke (large artery atherosclerosis) ( 29531354)
- LDL cholesterol ( 24097068 30275531 25961943 20686565)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Lipid or lipoprotein levels ( 23696881)
- Lipoprotein (a) levels ( 26377243 30108283 28512139)
- Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention) ( 31186284)
- Lipoprotein phospholipase A2 activity in cardiovascular disease ( 28753643)
- Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms ( 28512139)
- Lipoprotein-associated phospholipase A2 activity change in response to statin therapy ( 23118302)
- Lp (a) levels ( 21900290 19124843)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (antithrombotic agents) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Medication use (salicylic acid and derivatives) ( 31015401)
- Medication use (vasodilators used in cardiac diseases) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolite levels (lipoprotein measures) ( 27005778)
- Minimum ankle–brachial index ( 31285632)
- Monocyte early outgrowth colony forming units ( 21493818)
- Myocardial infarction ( 26343387)
- Parental lifespan ( 29030599)
- Parental longevity (both parents in top 10%) ( 29227965)
- Parental longevity (combined parental age at death) ( 29227965)
- Parental longevity (combined parental attained age, Martingale residuals) ( 29227965)
- Parental longevity (father's age at death) ( 31484785 29227965)
- Parental longevity (father's attained age) ( 29227965)
- Parental longevity (mother's age at death or mother's attained age) ( 31484785)
- Parental longevity (mother's age at death) ( 29227965)
- Parental longevity (mother's attained age) ( 29227965)
- Peripheral artery disease ( 31285632)
- Plasma plasminogen levels ( 25208887)
- Protein quantitative trait loci ( 18464913)
- Response to statin therapy ( 22368281)
- Response to statins (LDL cholesterol change) ( 25350695 22331829)
- Total cholesterol levels ( 28334899 30275531)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglycerides ( 30275531 25961943)
|
Interacting Genes |
51 interacting genes:
ALB
ANAPC10
ANKRA2
ANKS1B
APBA2
APBB1
APOB
APOE
APOH
APP
ATN1
CDC42
CLU
CUBN
DAB1
DAB2
DLG1
DLG2
DLG3
DLG4
GC
GIPC1
GPRASP1
INS
ITGB1BP1
LCN2
LDLRAP1
LPA
LPL
LRP2BP
LRPAP1
MAGI1
MAPK8IP1
MAPK8IP2
MDK
NOS1AP
PIP5K1C
PLAU
RAC1
RBP1
RHOA
SCGB1A1
SCN3A
SERPINE1
SLC9A3
SNX17
SYNJ2BP
TG
THBS1
TLN1
TTR
|
9 interacting genes:
APOH
CANX
CELA1
ELANE
FBLN5
FGB
FN1
LRP2
MMP12
|
Entrez ID |
4036 |
4018 |
HPRD ID |
02509 |
01063 |
Ensembl ID |
ENSG00000081479
|
ENSG00000198670
|
Uniprot IDs |
P98164
Q7Z5C0
Q7Z5C1
|
|
PDB IDs |
2M0P
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|